| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 269, Issue 1 193-R200, Copyright © 1995 by American Physiological Society
ARTICLES |
K. Nakanishi, D. L. Mattson, V. Gross, R. J. Roman and A. W. Cowley Jr
Department of Physiology, Medical College of Wisconsin, Milwaukee 53226, USA.
Experiments were performed in anesthetized renal-denervated rats to determine the contribution of renal medullary vasopressin V1 and V2 receptor stimulation in the regulation of renal medullary blood flow. Renal medullary interstitial infusion of the selective V1 agonist [Phe2,Ile3,Orn8]vasopressin (2 ng.kg-1.min-1) significantly decreased outer medullary blood flow by 15% and inner medullary blood flow by 35%, as measured with implanted optical fibers for laser-Doppler flowmetry. Medullary interstitial infusion of equimolar doses of arginine vasopressin (AVP) also decreased outer medullary blood flow by 15% but decreased inner medullary blood flow by only 17%, a decrease significantly less than that during the infusion of the V1 agonist. These results were confirmed in videomicroscopy experiments on the exposed papilla, which demonstrated that the V1 agonist and AVP decreased descending and ascending vasa recta capillary red blood cell velocity and calculated blood flow, with greater decreases during infusion of the V1 agonist. In further laser-Doppler flowmetry studies, stimulation of V2 receptors by medullary interstitial infusion of 1-desamino-8-D-arginine vasopressin (2 ng.kg-1.min-1) or AVP in rats pretreated with the vasopressin V1 receptor antagonist d(CH2)5[Tyr(Me)2,Ala-NH2]AVP increased renal medullary blood flow by 16 +/- 3 and 27 +/- 8%, respectively. The present experiments indicate that vasopressin V1 receptor stimulation serves to decrease renal medullary blood flow while V2 receptor stimulation appears to increase renal medullary blood flow; however, the net effect of AVP is to decrease renal medullary blood flow.
This article has been cited by other articles:
|
|
 |
|
  A. Hassan, Y. Tian, W. Zheng, H. Ji, K. Sandberg, and J. G. Verbalis Small interfering RNA-mediated functional silencing of vasopressin V2 receptors in the mouse kidney Physiol Genomics, May 11, 2005; 21(3): 382 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Zhang, T. Pibulsonggram, and A. Edwards Determinants of basal nitric oxide concentration in the renal medullary microcirculation Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1189 - F1203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Cowley Jr., T. Mori, D. Mattson, and A.-P. Zou Role of renal NO production in the regulation of medullary blood flow Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1355 - R1369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Mattson Importance of the renal medullary circulation in the control of sodium excretion and blood pressure Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R13 - R27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Dahly, K. M. Hoagland, A. K. Flasch, S. Jha, S. R. Ledbetter, and R. J. Roman Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R757 - R767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Yuan and A. W. Cowley Jr Evidence That Reduced Renal Medullary Nitric Oxide Synthase Activity of Dahl S Rats Enables Small Elevations of Arginine Vasopressin to Produce Sustained Hypertension Hypertension, February 1, 2001; 37(2): 524 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Thomas Inner medullary lactate production and accumulation: a vasa recta model Am J Physiol Renal Physiol, September 1, 2000; 279(3): F468 - F481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Szentivanyi Jr, F. Park, C. Y. Maeda, and A. W. Cowley Jr Nitric Oxide in the Renal Medulla Protects From Vasopressin-Induced Hypertension Hypertension, March 1, 2000; 35(3): 740 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Cowley Jr., M. M. Skelton, and T. M. Kurth Effects of long-term vasopressin receptor stimulation on medullary blood flow and arterial pressure Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1998; 275(5): R1420 - R1424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Park, A.-P. Zou, and A. W. Cowley Jr Arginine Vasopressin–Mediated Stimulation of Nitric Oxide Within the Rat Renal Medulla Hypertension, November 1, 1998; 32(5): 896 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bergstrom and R. G. Evans Effects of renal medullary infusion of a vasopressin V1 agonist on renal antihypertensive mechanisms in rabbits Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R76 - R85. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Park, D. L. Mattson, L. A. Roberts, and A. W. Cowley Jr. Evidence for the presence of smooth muscle alpha -actin within pericytes of the renal medulla Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1997; 273(5): R1742 - R1748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. V. Prasad, R. R. Edelman, and F. H. Epstein Noninvasive Evaluation of Intrarenal Oxygenation With BOLD MRI Circulation, December 15, 1996; 94(12): 3271 - 3275. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
